Development of Stem Cell-Based Platforms for Studying Microbial-Cellular Interactions: New Perspectives in Biotechnology and Therapeutic Innovation

Development of Stem Cell-Based Platforms for Studying Microbial-Cellular Interactions: New Perspectives in Biotechnology and Therapeutic Innovation

Nazanin Fatemeh Esmaeili1

1) Master of Microbiology (Pathogenic Microorganisms), Roudehen Branch, Islamic Azad University, Roudehen, Iran

IOI Code : ABEB-ABFADF
Publication : 4th International Conference on Recent Advances in Engineering, Innovation and Technology - Belgium(eitconf.com)
Abstract :
    Microbial–host interactions are central to the pathogenesis of infectious diseases, yet conventional in vitro and animal models struggle to recapitulate human physiological complexity, limiting translational impact. Recognizing this gap, recent advances in stem cell technology have enabled the engineering of human organoids and organ-on-chip systems that provide unprecedented fidelity in mimicking native tissue structure, cellular diversity, and microenvironmental cues. The aim of this review is to synthesize current knowledge on the development and application of stem cell–based platforms for modeling microbial-cellular interactions, emphasizing their value in biotechnology and therapeutic innovation. Methods: An extensive literature analysis was performed, focusing on primary studies and recent reviews covering stem cell differentiation, organoid technology, microfluidics, biomaterial innovation, and biosensor integration. We critically assessed how various stem cell sources—embryonic, induced pluripotent, and lineage-committed adult stem cells—are harnessed and combined with bioengineering tools to construct platforms for pathogen interaction modeling, drug screening, and personalized therapy discovery. Findings: The review shows that stem cell-derived organoids and organ-on-chips mirror human tissue architecture, allowing for dynamic analysis of pathogen colonization, host cell responses, and cellular crosstalk far more accurately than traditional monolayer cultures. Innovative bioengineered matrices, nanoplatforms, and integrated biosensors have greatly enhanced the functionality of these models, supporting the controlled delivery and real-time monitoring of antimicrobials, immunotherapies, and diagnostic markers. Case studies highlight success in modeling infections within neural, hepatic, and epithelial contexts, enabling predictive evaluation of drug efficacy and toxicity. Moreover, tailored gene-editing strategies and high-throughput screening approaches accelerate discovery and translation of new therapeutic modalities. Conclusion: Stem cell–based modeling systems are catalyzing a paradigm shift in infection biology and drug development, bridging the gap between bench and bedside. While further advances are needed in standardization, immune system integration, and scalability, these platforms hold transformative promise for precision biotechnology, safer therapies, and personalized medicine in combating infectious diseases.

Keywords : stem cell platforms organoids microbial host interactions biotechnology therapeutic innovation